AT
Abin Thomas
Cardiff University, King Abdullah International Medical Research Center, Indian Institute of Technology Dhanbad, Mahatma Gandhi University, Tata Consultancy Services (India)
0000-0002-8283-6762
Employment
-
Cardiff University Research Fellow2020 - Present
-
King Abdullah International Medical Research Center Biostatistician2015 - 2020
-
Tata Consultancy Services (India) Business Process Lead/ Analyst2011 - 2014
Education
-
Indian Institute of Technology Dhanbad PhD2015 - 2021
-
Mahatma Gandhi University MSc2009 - 2011
-
Mahatma Gandhi University BSc2006 - 2009
Projects & Funding
Projects & funding information is unavailable.
Publications (27)
- CPX-351 vs daunorubicin, cytarabine, and gemtuzumab ozogamicin in older adults with non–adverse-risk AML: the NCRI AML18 trial Save
- Combining Quizartinib with intensive chemotherapy in older patients with newly diagnosed AML: results of the UK NCRI AML18 Trial Save
- Safety and efficacy of combining midostaurin and gemtuzumab ozogamicin with induction chemotherapy in FLT3-mutated AML Save
- A revised prognostic model for patients with acute myeloid leukemia and first relapse Save
- Reply to: Treatment Intensification Based on Residual Disease in Elderly Patients With AML Save
- Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From the NCRI AML18 Trial Save
- Risk Stratification in Older Intensively Treated Patients With AML Save
- Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trial Save
- An efficient confidence interval estimation for prevalence calculated from misclassified data Save
- Predicting Patients’ Intention to Use a Personal Health Record Using an Adapted Unified Theory of Acceptance and Use of Technology Model: Secondary Data Analysis (Preprint) Save